In the past month, several Indian companies received FDA approvals for plants after waiting for several months.
Lupin and Dr Reddy’s got approvals for large manufacturing facilities in Pithampur and Srikakulam last month.
Biocon’s novel biologic Itolizumab has shown encouraging results for treating some Covid-19 related conditions. Itolizumab, a drug used to treat psoriasis was commercialized in India in 2013.
AIIMS Bhopal claims good results in trials of the drug Mycobacterium W (Mw) conducted on COVID-19 patients.
Gilead Sciences has signed voluntary patent licensing agreements with four Indian pharma companies, giving rights to manufacture and sell the drug Remdesivir to 127 countries.
Remdesivir is presently considered the most promising candidate for the treatment of COVID-19.
Treating COVID-19 patients with the malaria drug hydroxychloroquine (HCQ) had no positive effect and caused other health complications, said two new studies in France and China.
As part of WHO’s Solidarity trial, Indian will evaluate potential anti-viral agents remdesivir, chloroquine/hydroxychloroquine, lopinavir-ritonavir and lopinavir-ritonavir with interferon.
Glenmark Pharmaceuticals became the first company in India to initiate Phase 3 clinical trials on antiviral drug Favipiravir to check its efficacy on COVID-19 patients.
Favipiravir, which is a generic version of Japan-based Fujifilm Toyama Chemical’s Avigan, has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections.
Goa-based Molbio Diagnostics’ device called Truenat is set to become one of the key diagnostic tools for Covid-19.
Tocilizumab, a biological drug, is among the most keenly considered repurposed drugs that are likely to help in the fight against Covid-19.
Bhagawati Products that produces gadgets under Micromax brand has entered into an agreement with TWorks, a Telangana government initiative, to manufacture the mechanical ventilators.
TVS group, Sundaram Medical Foundation and IIT-Madras have jointly developed a low-cost, automated respiratory assist device called The Sundaram Ventago.